Javascript must be enabled to continue!
Insulin Icodec Weekly: A Basal Insulin Analogue for Type 2 Diabetes
View through CrossRef
Insulin icodec is a once-weekly basal insulin analogue in late-phase clinical development. Similar efficacy and safety of icodec to once-daily basal insulin analogues have been reported in over 4,200 participants with type 2 diabetes from three phase II and five phase III trials. Indeed, glycated haemoglobin reduction was superior for icodec among insulin-naïve participants (ONWARDS 1, 3 and 5) and in those switching from a daily basal insulin in ONWARDS 2, with the latter trial demonstrating improved diabetes treatment satisfaction scores with insulin icodec versus insulin degludec.
Title: Insulin Icodec Weekly: A Basal Insulin Analogue for Type 2 Diabetes
Description:
Insulin icodec is a once-weekly basal insulin analogue in late-phase clinical development.
Similar efficacy and safety of icodec to once-daily basal insulin analogues have been reported in over 4,200 participants with type 2 diabetes from three phase II and five phase III trials.
Indeed, glycated haemoglobin reduction was superior for icodec among insulin-naïve participants (ONWARDS 1, 3 and 5) and in those switching from a daily basal insulin in ONWARDS 2, with the latter trial demonstrating improved diabetes treatment satisfaction scores with insulin icodec versus insulin degludec.
Related Results
Once-weekly Insulin Icodec – An emerging treatment option for type 2 Diabetes
Once-weekly Insulin Icodec – An emerging treatment option for type 2 Diabetes
The treatment of diabetes often necessitates the administration of exogenous insulin, but research shows that patients are less compliant with administering insulin daily. The main...
Exploring the Efficacy of Once and Twice Weekly Thyroxine Dosing: A Promising Approach for Hypothyroidism Management
Exploring the Efficacy of Once and Twice Weekly Thyroxine Dosing: A Promising Approach for Hypothyroidism Management
Abstract
Introduction
Hypothyroidism is a common endocrine disorder, in which the management involves daily intake of thyroxine. However, adherence to a daily medication regimen po...
Pregnancy and Challenging Transient Anti-GAD65 Positivity: A Case Report with Literature Review
Pregnancy and Challenging Transient Anti-GAD65 Positivity: A Case Report with Literature Review
Abstract
Introduction
During pregnancy, women may develop blood glucose abnormalities like gestational diabetes mellitus (GDM) or, rarely, type 1 diabetes (T1D), which can lead to ...
Efficacy and safety of once-weekly insulin icodec compared to once-daily insulin g U-100 in patients with type II diabetes: a systematic review and meta-analysis
Efficacy and safety of once-weekly insulin icodec compared to once-daily insulin g U-100 in patients with type II diabetes: a systematic review and meta-analysis
Abstract
Background//Objective
Diabetes affects millions of people globally, despite treatment options, adherence and other factors pose obstacles. ...
Diabetes Mellitus: Life Style, Obesity and Insulin Resistance
Diabetes Mellitus: Life Style, Obesity and Insulin Resistance
In millennia, 40 million people were died with non-communicable diseases and diabetes is one of them. In diabetes, insulin secretions are not produced properly or resist to body an...
A case of once-weekly basal insulin therapy for a dementia patient with Type 2 Diabetes mellitus and living alone
A case of once-weekly basal insulin therapy for a dementia patient with Type 2 Diabetes mellitus and living alone
A
BSTRACT
Living alone may be one of the risk factors not only for patients with dementia, but also for dementia patients w...
Insulin Lispro: Its Role in the Treatment of Diabetes Mellitus
Insulin Lispro: Its Role in the Treatment of Diabetes Mellitus
OBJECTIVE:
To introduce a rapid-acting human insulin analog, insulin lispro; to review its pharmacology, therapeutics, pharmacokinetics, dosing guidelines, adve...
Pathogenesis of Type 2 Diabetes
Pathogenesis of Type 2 Diabetes
AbstractThe sections in this article are:Insulin Secretion in T2DMFasting Insulin ConcentrationGlucose‐Stimulated Insulin SecretionOther Abnormalities in Insulin Secretion in T2DMM...

